CONTACT HOME ABOUT US RESEARCH AND TECHNOLOGY EDUCATION AND TRAINING CAREERS AND JOBS OUR EVENTS PUBLICATIONS Home About us Publications The scientific productivity of the Department of Experimental Oncology (DEO) has remained stable over the years, highlighting the high-level standard of this department. In the past seven years, a total of 768 papers have been published in peer-reviewed journals, with an average of about 100 papers every year, resulting into an Impact Factor (IF) close to 9.1. Notably, 26% of total publications were issued in journals with an IF higher than 10, including Cell and Nature magazines (Cell, Cancer Cell, Cell Stem Cell, Molecular Cell, Nature, Nature Medicine, Nature Biotechnology, Nature Immunology, Nature Methods, Nature Reviews in Cancer, Nature Reviews in Immunology), Science, New England Journal of Medicine and Annual Reviews in Immunology. The complete publication records, authored by DEO-affiliated scientists, can be obtained using the following interactive system, which enables to search either for year, journal, author, or IF. clear filters SEARCH 1 2 3 4 5 6 7 8 9 10 ... Page 1 of 202 Bizzaro F, Fuso Nerini I, Taylor MA, Anastasia A, Russo M, Damia G, Guffanti F, Guana F, Ostano P, Minoli L, Hattersley MM, Arnold S, Ramos-Montoya A, Williamson SC, Galbiati A, Urosevic J, Leo E, Cavallaro U, Ghilardi C, Barry ST, Bani MR, Giavazzi R VEGF pathway inhibition potentiates PARP inhibitor efficacy in ovarian cancer independent of BRCA status. J Hematol Oncol, 2021 Keim U, Gandini S, Amaral T, Katalinic A, Holleczek B, Flatz L, Leiter U, Whiteman D, Garbe C Cutaneous melanoma attributable to UVR exposure in Denmark and Germany. Eur J Cancer, 2021 Sichero L, Tagliabue M, Mota G, Ferreira S, Nunes RAL, Castañeda CA, Castillo M, Correa RM, Perdomo S, Rodríguez-Urrego PA, Matos LL, Mohssen A, Gheit T, Tommasino M, Chiocca S, Villa LL; HEADLAcE Study Group Biomarkers of human papillomavirus (HPV)-driven head and neck cancer in Latin America and Europe study: Study design and HPV DNA/p16INK4a status. Head Neck, 2021 Dokla EME, Abdel-Aziz AK, Milik SN, Mahmoud AH, Saadeldin MK, McPhillie MJ, Minucci S, Abouzid KAM Indolin-2-one derivatives as selective Aurora B kinase inhibitors targeting breast cancer. Bioorg Chem, 2021 Zorzi SF, Lazio MS, Pietrobon G, Chu F, Zurlo V, Bibiano D, De Benedetto L, Cattaneo A, De Berardinis R, Mossinelli C, Alterio D, Rocca MC, Gandini S, Gallo O, Chiocca S, Tagliabue M, Ansarin M Upfront surgical organ-preservation strategy in advanced-stage laryngeal cancer. Am J Otolaryngol, 2021 Buttiron Webber T, Provinciali N, Musso M, Ugolini M, Boitano M, Clavarezza M, D'Amico M, Defferrari C, Gozza A, Briata IM, Magnani M, Paciolla F, Menghini N, Marcenaro E, De Palma R, Sacchi N, Innocenti L, Siri G, D'Ecclesiis O, Cevasco I, Gandini S, DeCensi A Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment. Eur J Cancer, 2021 Carloni S, Bertocchi A, Mancinelli S, Bellini M, Erreni M, Borreca A, Braga D, Giugliano S, Mozzarelli AM, Manganaro D, Fernandez Perez D, Colombo F, Di Sabatino A, Pasini D, Penna G, Matteoli M, Lodato S, Rescigno M Identification of a choroid plexus vascular barrier closing during intestinal inflammation. Science, 2021 Cerutti E, D'Amico M, Cainero I, Dellino GI, Faretta M, Vicidomini G, Pelicci PG, Bianchini P, Diaspro A, Lanzanò L Evaluation of sted super-resolution image quality by image correlation spectroscopy (QuICS). Sci Rep, 2021 Pellegrini C, Raimondi S, Di Nardo L, Ghiorzo P, Menin C, Manganoni MA, Palmieri G, Guida G, Quaglino P, Stanganelli I, Massi D, Pastorino L, Elefanti L, Tosti G, Queirolo P, Leva A, Maurichi A, Rodolfo M, Fargnoli MC; Italian Melanoma Intergroup (IMI) Melanoma in children and adolescents: analysis of susceptibility genes in 123 Italian patients. J Eur Acad Dermatol Venereol, 2021 Malla B, Guo X, Senger G, Chasapopoulou Z, Yildirim F A Systematic Review of Transcriptional Dysregulation in Huntington's Disease Studied by RNA Sequencing. Front Genet, 2021 1 2 3 4 5 6 7 8 9 10 ... Page 1 of 202 Privacy policy Cookie policy Contact ®2021 Istituto Europeo di Oncologia - via Ripamonti 435 Milano - P.I. 08691440153 IEO.it Our site uses cookies for better browsing usability and statistics on its use. If you want to learn more, or refuse consent to all or some cookies, click here. I AGREE